Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The S8 Sinus Implant is referenced as a drug-eluting sinus implant designed to maintain patency of the sinus ostia following endoscopic sinus surgery. These types of implants are typically used in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) or chronic sinusitis who have undergone prior surgical intervention and are at risk for recurrent obstruction due to inflammation, scarring, or polyp regrowth. The implant is generally made from bioabsorbable polymers and releases a corticosteroid (commonly mometasone furoate) locally over an extended period (up to 90 days), reducing local inflammation, edema, and the need for further surgical interventions[1][5][7]. The device is placed by a physician under endoscopic visualization and expands radially to conform to the surgically enlarged ostium[5]. It may be removed after a set period or left in place if bioabsorbable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on S8 Sinus Implant.